HOME >> MEDICINE >> NEWS
Clinical trial of Etanercept for Wegener's disease shows no benefit

A Johns Hopkins-led study designed to evaluate the ability of etanercept to maintain disease remissions in a serious autoimmune disorder has failed to show any benefit. Etanercept, also called Enbrel, is a common treatment for rheumatoid arthritis and other types of joint inflammation.

"We had hoped that this approach to the treatment of Wegener's granulomatosis would be useful in preventing disease relapses," says John H. Stone, M.D., associate professor of medicine, director of the Johns Hopkins Vasculitis Center, and lead investigator of the study published in the Jan. 27, 2005, issue of the New England Journal of Medicine.

"The study results, however, demonstrate unequivocally that etanercept was not effective for this purpose. Because of the disease's propensity to flare following remission and the high risk of treatment complications associated with conventional therapies for Wegener's, we must continue to look for safe, effective ways of achieving and maintaining disease remissions," said Stone.

Wegener's granulomatosis is an uncommon disorder in which the body's immune system attacks its own blood vessels, damaging vital organs by limiting the flow of blood to lungs, kidneys, upper airways and other organs. The disease can affect people of any age and occurs in men and women with equal frequency.

Although current medications used to treat Wegener's halt the disease temporarily in most patients, 60 to 80 percent of patients eventually suffer from disease flares. The need to treat many patients repeatedly with medications such as glucocorticoids (prednisone), cyclophosphamide, and methotrexate leads to mounting morbidity from treatments. At the same time, each disease flare has the potential to cause irreversible damage. Wegener's granulomatosis frequently leads to kidney failure, hearing loss, damage to the respiratory tract, peripheral nerve injury, and other complications, according to Stone.

Etanercept, the f
'"/>

Contact: Trent Stockton
tstockt1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
26-Jan-2005


Page: 1 2 3

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial participants fare no better, no worse than other patients
3. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
4. National Academies news: Clinical research involving children
5. Clinical research key in advance to prospective health care
6. Clinical trial of new TB vaccine begins
7. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
8. Clinical factors useful to identify heart failure patients with high risk of death
9. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
10. $7 million grant continues Asthma Clinical Research Network efforts
11. Clinical study of Penn State Hershey technology begins in South Africa

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... August 19, 2019 , ... A July 26 article ... be brushing their pets’ teeth twice a day. The acknowledges that, with dogs not ... suggests that close monitoring and brushing at least twice a week is likely enough ...
(Date:8/17/2019)... ... 2019 , ... Approximately 50 area youth between the ages ... program sponsored by United Concordia Dental and Mission Arlington/Metroplex. , “We value our ... make these services available to area youths who are uninsured or underinsured,” says ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the CBD market in the United ... its crowdfunding campaign to raise $50 million on September 9, 2019. , Established ...
(Date:8/16/2019)... , ... August 16, 2019 , ... ... safety professionals from throughout the Mid-Atlantic and North East at the 2019 Safety ... was engineered to build on existing construction safety concepts and define not only ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... residents who have been directly affected by the closure of Hahnemann University Hospital ... gathered during the campaign, the ASCP Foundation will be making hardship grants of ...
Breaking Medicine News(10 mins):
(Date:8/19/2019)... ... August 19, 2019 , ... Transformations Substance Abuse ... Sports Summit, August 25-26 at the Hyatt Place in Delray Beach, FL, once ... professional sports programs to discuss progress made over the last year in the ...
(Date:8/19/2019)... ... August 19, 2019 , ... Physician Partners of America Pain ... Richardson, Texas location, starting Monday, Sep. 2nd. , Dr. Spiro Khoury is board ... certification in pain management. , Dr. Khoury attended the American University of the ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... received FDA approval, providing an alternative that both corrects the curve and maintains ... uses patented methods and techniques developed by medical staff of Shriners Hospitals for ...
Breaking Medicine Technology:
Cached News: